PepGen Inc. (PEPG)
$2.49-4.96%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $172M
- Beta
- 1.97
- P/E (TTM)
- -1.54
- Short % float
- 11.72%
- Days to cover
- 4.8
- SI change
- +9.2%
- 1W
- +5.51%
- 1M
- -16.44%
- vs SPY 1W
- +5.09%
- vs SPY 1M
- -18.50%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PEPG?
- LOPJLB’s latest quantitative signal on PepGen Inc. (PEPG) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PEPG in?
- PepGen Inc. (PEPG) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does PepGen Inc. (PEPG) do?
- PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the trea…